Women are and will be the predominant users of GLP-1 users, but research gaps remain critical
GLP-1s appear safe for treating diabetes in pregnancy, but evidence gaps remain.
← Back to stories
2 articles from 1 source across the spectrum· Updated 7d ago
1 across the spectrum · tap a section to jump
Left
0 viewpointsNo Left coverage yet.
A blind spot on this side of the story.
Center
1 viewpointWomen are and will be the predominant users of GLP-1 users, but research gaps remain critical
GLP-1s appear safe for treating diabetes in pregnancy, but evidence gaps remain
Right
0 viewpointsNo Right coverage yet.
A blind spot on this side of the story.